Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$26.43 - $32.77 $16,915 - $20,972
640 Added 7.11%
9,638 $288,000
Q4 2023

Feb 09, 2024

SELL
$27.94 - $35.44 $12,712 - $16,125
-455 Reduced 4.81%
8,998 $286,000
Q2 2023

Aug 11, 2023

SELL
$37.4 - $42.94 $935 - $1,073
-25 Reduced 0.26%
9,453 $359,000
Q1 2023

May 12, 2023

SELL
$34.88 - $43.22 $27,624 - $34,230
-792 Reduced 7.71%
9,478 $357,000
Q4 2022

Feb 10, 2023

SELL
$33.8 - $47.06 $53,065 - $73,884
-1,570 Reduced 13.26%
10,270 $435,000
Q3 2022

Nov 10, 2022

SELL
$31.52 - $373.61 $4,917 - $58,283
-156 Reduced 1.3%
11,840 $380,000
Q1 2022

May 11, 2022

BUY
$30.95 - $39.68 $9,594 - $12,300
310 Added 2.65%
11,996 $434,000
Q4 2021

Feb 09, 2022

SELL
$35.87 - $47.12 $5,703 - $7,492
-159 Reduced 1.34%
11,686 $462,000
Q2 2021

Aug 09, 2021

BUY
$32.88 - $44.57 $4,077 - $5,526
124 Added 1.06%
11,845 $484,000
Q1 2021

May 12, 2021

SELL
$30.92 - $44.4 $8,874 - $12,742
-287 Reduced 2.39%
11,721 $385,000
Q3 2020

Nov 13, 2020

SELL
$33.07 - $38.68 $9,689 - $11,333
-293 Reduced 2.38%
12,008 $440,000
Q1 2020

May 11, 2020

BUY
$17.15 - $25.22 $13,719 - $20,176
800 Added 6.96%
12,301 $261,000
Q4 2019

Feb 11, 2020

BUY
$18.88 - $24.14 $4,455 - $5,697
236 Added 2.09%
11,501 $257,000
Q3 2019

Nov 12, 2019

BUY
$18.0 - $21.38 $202,770 - $240,845
11,265 New
11,265 $228,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Argent Trust CO Portfolio

Follow Argent Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.